STOCK TITAN
  1. Home
  2. Sec-filings
  3. ETST
  4. [8-K] Earth Science Tech, Inc. Reports Material Event

Earth Science Tech, Inc. (OTC: ETST) boosts Q1 profit and cash flow

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Earth Science Tech, Inc. reported fiscal first quarter 2027 results for the period ended June 30, 2026, showing modest revenue growth and much stronger profitability. Revenue was $9.0 million compared to $8.8 million, with gross profit of $6.3 million compared to $6.1 million.

Net income rose 57% to $715,697 from $456,714, and diluted EPS more than tripled to $0.003 from $0.001. Net cash provided by operating activities increased 108.4% to $707,131 from $339,376, and total assets reached $10.4 million on June 30, 2026, up from $7.8 million a year earlier. All key operating subsidiaries were profitable. The company repurchased and retired over 3.7 million shares of common stock during the quarter, compared to 505,000 in the prior-year period, without adding debt. An Annual Meeting on August 31, 2026 will address proposals including cancellation of Series B Preferred Stock and discussion of a potential exchange uplisting.

Positive

  • Net income increased 57% year-over-year to $715,697, with diluted EPS more than tripling to $0.003, indicating sharply improved profitability in fiscal first quarter 2027.
  • Operating cash flow grew 108.4% to $707,131, while total assets rose to $10.4 million, reflecting stronger cash generation and a larger asset base.
  • Share repurchases exceeded 3.7 million shares, up from 505,000 a year earlier, and were completed without adding debt, reducing share count while maintaining capital discipline.

Negative

  • None.
Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Revenue $9.0 million Fiscal first quarter 2027 revenue; compared to $8.8 million in the prior-year period
Gross profit $6.3 million Fiscal first quarter 2027 gross profit; compared to $6.1 million in the prior-year period
Net income $715,697 Up 57% compared to $456,714 for the three months ended June 30, 2025
Diluted EPS $0.003 Fiscal first quarter 2027 diluted earnings per share; compared to $0.001 in prior-year quarter
Operating cash flow $707,131 Net cash provided by operating activities; an increase of 108.4% vs. $339,376 prior year
Total assets $10.4 million Total assets on June 30, 2026; compared to $7.8 million on June 30, 2025
Share repurchases over 3.7 million shares Common shares repurchased and retired in fiscal first quarter 2027; prior year 505,000 shares
diluted earnings per share financial
"diluted earnings per share were $0.003, compared to $0.001"
Diluted earnings per share is a measure of a company's profit allocated to each share of stock, taking into account all possible shares that could be created through stock options, convertible bonds, or other securities. It shows the lowest possible earnings per share if all these potential shares were issued, helping investors understand the worst-case scenario for their ownership. This figure matters because it provides a more conservative view of a company's profitability per share.
operating activities financial
"Net cash provided by operating activities was $707,131"
Operating activities are the core actions a business takes to run its everyday operations and generate revenue. This includes activities like selling products or services, paying employees, and managing inventory. For investors, understanding operating activities helps gauge how well a company is performing its main functions and whether it can sustain its profitability over time.
Series B Preferred Stock financial
"proposed cancellation of the Series B Preferred Stock, a strategic governance move"
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
exchange uplisting regulatory
"evaluation of a potential near-term exchange uplisting to improve trading liquidity"
telehealth medical
"broaden ETST’s telehealth and pharmacy fulfillment platforms into new, complementary verticals"
Telehealth is the delivery of healthcare services and consultations remotely using video calls, phone, text messaging, or connected devices to monitor and transmit medical information. It matters to investors because it can reshape how patients access care, lower costs, and create new revenue streams or risks for healthcare providers, insurers and technology companies—similar to how online banking changed financial services—while also exposing businesses to reimbursement and regulatory shifts.
Revenue $9.0 million compared to $8.8 million for the prior-year period
Gross profit $6.3 million compared to $6.1 million for the prior-year period
Net income $715,697 up 57% compared to $456,714 for the three months ended June 30, 2025
Diluted EPS $0.003 compared to $0.001 in the prior-year period
Net cash provided by operating activities $707,131 an increase of 108.4% compared to $339,376
Total assets $10.4 million compared to $7.8 million on June 30, 2025

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What were Earth Science Tech (ETST)'s fiscal Q1 2027 revenue and net income?
Earth Science Tech (ETST) generated $9.0 million in revenue and $715,697 in net income in fiscal first quarter 2027. Revenue rose from $8.8 million, while net income increased 57% from $456,714 for the three months ended June 30, 2025.

How did ETST's earnings per share change in fiscal Q1 2027?
Diluted earnings per share for ETST more than tripled to $0.003 in fiscal Q1 2027. This compares with diluted EPS of $0.001 in the prior-year quarter, reflecting significantly higher profitability on a per-share basis.

How much operating cash flow did ETST generate in fiscal Q1 2027?
ETST generated $707,131 in net cash provided by operating activities in fiscal Q1 2027. This represented an increase of 108.4% compared to $339,376 in the prior-year period, showing stronger cash conversion from its operations.

How many shares did Earth Science Tech (ETST) repurchase in fiscal Q1 2027?
Earth Science Tech repurchased and retired over 3.7 million shares of common stock in fiscal Q1 2027. This compares with 505,000 shares repurchased in the same quarter a year earlier, and management stated it did so without adding debt.

When is ETST's 2026 Annual Meeting and what key items will be discussed?
ETST's Annual Meeting of Shareholders is scheduled for August 31, 2026, at 5:00 p.m. E.T. Key topics include voting on the proposed cancellation of Series B Preferred Stock and discussion of a potential near-term exchange uplisting to enhance liquidity and visibility.

What is Earth Science Tech (ETST)'s business focus?
Earth Science Tech operates as a diversified holding company in the health and wellness sector. Its strategy is to build a vertically integrated healthcare platform combining compounding pharmacies, telemedicine, clinical support, and direct-to-patient fulfillment, supported by real estate, asset management, and consumer products activities.
false 0001538495 0001538495 2026-08-07 2026-08-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 7, 2026

 

Commission File No. 000-55000

 

EARTH SCIENCE TECH, INC.

(Exact name of registrant as specified in its charter)

 

florida   45-4267181
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

 

8950 SW 74 th CT

Suite 1401

Miami, FL 33156, USA

(Address of principal executive offices, zip code)

(305) 724-5684

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of Each Class   Trading Symbol   Name of each exchange on which registered
Common Stock $0.001 par value   ETST   Over the Counter Bulletin Board

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition

 

On August 7, 2026, Earth Science Tech, Inc., a Florida corporation (the “Company”) issued a press release (the “Release”), reporting its first fiscal quarter 2027 financial results for the period ended June 30, 2026.

 

A copy of the Release is attached hereto as Exhibit 99.1. The information contained in this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits – The following exhibits are filed as part of this report:

 

Exhibit No.   Description
99.1   Press release issued by the registrant on August 7, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  EARTH SCIENCE TECH, INC.
     
Dated: August 7, 2026 By: /s/ Giorgio R. Saumat
    Giorgio R. Saumat
  Its: CEO and Chairman of the Board

 

 

 

 

Exhibit 99.1

 

Earth Science Tech, Inc. (ETST) Reports Fiscal First Quarter 2027 Financial Results for the Period Ended June 30, 2026

 

  ● Net income grew 57% year-over-year to $715,697, with diluted EPS tripling to $0.003
  ● Net cash provided by operating activities grew 108% to $707,131
  ● All key operating subsidiaries profitable
  ● Repurchased and retired 3.7 million shares of common stock, an increase from 505,000 in the prior-year quarter

 

MIAMI, Aug 7, 2026 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on a diversified portfolio, today announced its financial results for the fiscal first quarter ended June 30, 2026.

 

“Our fiscal first quarter results reflect steady, compounding progress and the inherent operating leverage within our business model,” said Giorgio R. Saumat, CEO and Chairman of the Board of Earth Science Tech, Inc. “While revenue grew 3%, our net income increased 57% to $715,697, and diluted earnings per share more than tripled year-over-year. All of our key operating subsidiaries remained profitable this quarter, further strengthening our balance sheet. While we are pleased with the trajectory, we maintain rigorous internal standards and are actively focused on driving even greater operational efficiencies. Compared to where this business was just a few years ago, this quarter is further validation that our strategic platform is becoming increasingly efficient, diversified, and profitable.”

 

Mr. Saumat continued, “We also remain highly disciplined stewards of capital. During the quarter, we returned significant value to our shareholders by repurchasing and retiring more than 3.7 million shares of common stock, an increase from 505,000 shares in the same period last year, all without adding a dollar of debt to our balance sheet. This quarter underscores the durability of the foundation we established in fiscal 2026. Looking ahead, we are focused on scaling the business by expanding our geographic footprint, advancing our telehealth and pharmacy fulfillment platforms, and building long-term, sustainable shareholder value.”

 

Fiscal first quarter 2027 Financial Highlights:

 

● Revenue: $9.0 million, compared to $8.8 million.
● Gross profit: $6.3 million, compared to $6.1 million.

 

 

 

 

● Net income: $715,697, up 57% compared to $456,714 for the three months ended June 30, 2025. Diluted earnings per share were $0.003, compared to $0.001.
● Operating Cash Flow: Net cash provided by operating activities was $707,131 (an increase of 108.4%) compared to $339,376.
● Balance Sheet: Total assets were $10.4 million on June 30, 2026, compared to $7.8 million on June 30, 2025.
● Share Repurchases: The Company repurchased and retired over 3.7 million shares of common stock, compared to 505,000 shares in the prior-year-period.

 

Operational Highlights:

 

All key operating subsidiaries achieved profitability during the quarter, a continuing trend established in fiscal 2026 that further diversifies the Company’s earnings base beyond any single pharmacy or platform. The Company’s compounding pharmacy operations successfully continued to expand their licensing footprint across the United States. Concurrently, management is actively evaluating strategic opportunities to broaden ETST’s telehealth and pharmacy fulfillment platforms into new, complementary verticals.

 

Upcoming Annual Meeting of Shareholders and Strategic Initiatives:

 

Management will discuss these financial results and ongoing corporate initiatives at the Company’s Annual Meeting of Shareholders, scheduled for August 31, 2026, at 5:00 p.m. E.T.

 

The Annual Meeting will serve as an important forum to address shareholders feedback and vote on critical proposals designed to enhance long-term value. Key agenda items include the proposed cancellation of the Series B Preferred Stock, a strategic governance move intended to simplify the capital structure and attract a broader base of institutional investors. Additionally, management will discuss the evaluation of a potential near-term exchange uplisting to improve trading liquidity and broader market visibility.

 

Management strongly encourages all ETST shareholders of record to review the proxy materials and vote their shares.

 

To access the proxy materials and view the Annual Meeting, please visit:

https://www.cstproxy.com/earthsciencetech/2026/

 

 

 

 

About Earth Science Tech, Inc. (ETST)

 

Earth Science Tech, Inc. operates as a diversified holding company focused on the health and wellness sector. The Company’s principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company’s healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.

 

The core of the Company’s value proposition is the seamless integration of patient care, from consultation to fulfillment. This is achieved through the synergy of specialized subsidiaries.

 

To learn more, please visit: www.EarthScienceTech.com

 

Forward-Looking Statements

 

Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

 

Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

 

Contact:

 

Hayden IR

James Carbonara

(646)-755-7412

james@haydenir.com

 

Brett Maas

(646) 536-7331

brett@haydenir.com

 

 

 

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

Press Releases

Other Documents